RBC Cuts Enanta Pharmaceuticals' Price Target to $25 From $33, Keeps Sector Perform Rating Jul 7, 2023
An Ascending Megaphone with a small falling wedge (A bullish pattern) contained within it I expect price to break out bullishly to the upside out of this blue falling wedge structure This breakout will continue the megaphone Weekly timeframe
chart-art shows POSSIBLE uptrend , green trend-line means bullish . Over the ma line can_be 🐂, & under will be bearish Short to midterm . ~~N0 arrows. ~~ N0T trading Advise either +dyor
chart-art shows POSSIBLE uptrend , green trend-line means bullish . Over the ma line can_be 🐂, & under will be bearish Short to midterm . ~~N0 arrows. ~~ N0T trading Advise either +dyor pls .
chart-art shows POSSIBLE uptrend , green trend-line means bullish . Over the red fibo Level can_be 🐂, & under will be bearish Short to midterm . ~~N0 arrows. ~~ N0T trading Advise either +dyor
chart-art shows POSSIBLE uptrend , green trend-line means bullish . Over the red fibo Level can_be 🐂, & under will be bearish Short to midterm . ~~N0 arrows. ~~ N0T trading Advise either +dyor pls
chart-art shows POSSIBLE uptrend , green trend-line means bullish . Over the red fibo Level can_be 🐂, & under will be bearish Short to midterm . ~~N0 arrows. ~~ N0T trading Advise either +dyor pls.
The prices are dancing around the 200 weekly SMA and the level is a Fibonacci retracement of 0,618. I will try a long from this prices with an oscillation of 9-10% for the Stop Loss. If the count is correct we are assisting at the start of wave 5, this means to see the prices over the top of 3.
ValuEngine Forecast Models 1-Month 72.52 1.08% 3-Month 72.99 1.74% 6-Month 73.34 2.23%
An intraday high potential, Back Tested Long Analysis. We ll try to enter into the correction of the downtrend movement. DETAILS ON THE CHART NOTE: Entry range area above the entry point, is calculated upon 80% of the recorded pullback back tested past performances DISCLAIMER: This is a technical analysis study, not an advice or recommendation to...